Su Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Ubiquitin and proteasome pathways
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 7
- Heat shock proteins research 5
- Cancer-related gene regulation 3
- RNA modifications and cancer 3
- Glycosylation and Glycoproteins Research 2
- Plant biochemistry and biosynthesis 2
- Oncology 8
- Cancer-related Molecular Pathways 4
- Co-authors
- Huamei Tang (15 shared papers)Dongwang Yan (5 shared papers)Zhihai Peng (4 shared papers)Zehua Wu (4 shared papers)Guoqiang Qiu (3 shared papers)Zhihai Peng (9 shared papers)Han Yang (7 shared papers)Chongzhi Zhou (6 shared papers)
- Journals
- Oncology Reports (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)Medical Oncology (2 papers)Journal of Thoracic Oncology (1 paper)Biomedical Reports (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Su Lu
34 papers receiving 864 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 293
- Molecular Biology 478
- Oncology 142
- Immunology 87
- Cell Biology 56
Countries citing papers authored by Su Lu
This map shows the geographic impact of Su Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Lu more than expected).
Fields of papers citing papers by Su Lu
This network shows the impact of papers produced by Su Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Lu. The network helps show where Su Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Su Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 191 | |
| 2 | 2016 | 60 | |
| 3 | 2018 | 58 | |
| 4 | 2013 | 46 | |
| 5 | 2018 | 41 | |
| 6 | 2019 | 39 | |
| 7 | 2013 | 38 | |
| 8 | 2013 | 35 | |
| 9 | 2015 | 34 | |
| 10 | 2015 | 30 | |
| 11 | 2009 | 30 | |
| 12 | Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer. | 2014 | 26 |
| 13 | 2019 | 26 | |
| 14 | 2016 | 24 | |
| 15 | 2014 | 23 | |
| 16 | 2014 | 23 | |
| 17 | SERPINA4 is a novel independent prognostic indicator and a potential therapeutic target for colorectal cancer. | 2016 | 22 |
| 18 | 2015 | 19 | |
| 19 | 2014 | 18 | |
| 20 | 2014 | 16 |
About Su Lu
Su Lu is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cancer Research and Immunology, having authored 34 papers that have together received 870 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Heat shock proteins research (5 papers), Genetic factors in colorectal cancer (4 papers), Cancer-related Molecular Pathways (4 papers), Cancer-related gene regulation (3 papers), RNA modifications and cancer (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Plant biochemistry and biosynthesis (2 papers). The work is most often cited by research in Cancer Research (293 citations), Molecular Biology (478 citations), Oncology (142 citations), Immunology (87 citations) and Cell Biology (56 citations). Su Lu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Huamei Tang, Dongwang Yan, Zhihai Peng, Zehua Wu, Guoqiang Qiu, Zhihai Peng, Han Yang, Chongzhi Zhou, Jian Chen and Tao Jiang. Their work appears in journals such as Oncology Reports, Journal of Experimental & Clinical Cancer Research, Medical Oncology, Journal of Thoracic Oncology and Biomedical Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.